Biblio
Generation of two isogenic iPSC lines from a healthy male donor of European ancestry. Stem Cell Res. 2024;77:103403.
. Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene. Stem Cell Res. 2019;35:101403.
. Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology. Stem Cell Res. 2019;42:101667.
. Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9. Stem Cell Res. 2020;45:101804.
. Generation of two NAGLU-mutated homozygous cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 to model Sanfilippo B syndrome. Stem Cell Res. 2019;42:101668.
. Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells. PLoS One. 2016;11(7):e0159474.
. Generation of two patient specific GABRD variants and their isogenic controls for modeling epilepsy. Stem Cell Res. 2024;76:103372.
Generation of two patient-derived iPSC lines from siblings (LIBUCi001-A and LIBUCi002-A) and a genetically modified iPSC line (JMUi001-A-1) to mimic dilated cardiomyopathy with ataxia (DCMA) caused by a homozygous DNAJC19 mutation. Stem Cell Res. 2020;46:101856.
Generation of two PITX2 knock-out human induced pluripotent stem cell lines using CRISPR/Cas9 system. Stem Cell Res. 2022;65:102940.
. Generation of two RNF2 homozygous knockout human embryonic stem cell lines by CRISPR/Cas9 system. Stem Cell Res. 2020;47:101885.
. Generation of two spinal muscular atrophy (SMA) type I patient-derived induced pluripotent stem cell (iPSC) lines and two SMA type II patient-derived iPSC lines. Stem Cell Res. 2019;34:101376.
. Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing. Stem Cell Res. 2019;42:101673.
. Generation of two transgene-free human iPSC lines from CD133 cord blood cells. Stem Cell Res. 2019;36:101410.
. Generation of Urine-Derived Induced Pluripotent Stem Cell Line from Patients with Acute Kidney Injury. Cell Reprogram. 2021;23(5):290-303.
Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome. Stem Cell Rev Rep. 2023.
. Generation of urine-derived iPS cell line via a non-integrative method from a Barth syndrome patient with TAZ gene mutation. Stem Cell Res. 2020;47:101886.
. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015.
Generation of vascularized human cardiac organoids for 3D in vitro modeling. STAR Protoc. 2023;4(3):102371.
. Generation of Zebrafish Models of Human Retinitis Pigmentosa Diseases Using CRISPR/Cas9-Mediated Gene Editing System. Mol Biotechnol. 2023.
. Generation of ZJUi003-A, an induced pluripotent stem cell line from a Wilson's disease patient carrying a c.180_181del mutation in ATP7B gene. Stem Cell Res. 2020;46:101873.
. Generation of ZZUi008-A, a transgene-free, induced pluripotent stem cell line derived from chorionic villi cells of a fetus with Duchenne muscular dystrophy. Stem Cell Res. 2018;32:47-50.
. Generation of αMHC-EGFP knock-in in human pluripotent stem cell line, SNUe003-A-3 using CRISPR/Cas9-based gene targeting. Stem Cell Res. 2022;61:102779.
. .